China Pharma Holdings Inc.
CPHI
Market Cap$5.26M
Close$
$-0.36
122.5% downside
Current Fair Value
122.5% downsideOvervalued by 122.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $5.26 Million |
|---|---|
| Enterprise Value | $1.55 Trillion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-0.27 |
| Beta | 0.78 |
| Outstanding Shares | 3,261,911,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -0.01 |
|---|---|
| PEG | 0 |
| Price to Sales | 0.0 |
| Price to Book Ratio | 0.0 |
| Enterprise Value to Revenue | 0.49 |
| Enterprise Value to EBIT | -0.48 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 1.27 |
| Debt to Equity | 0.28 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About China Pharma Holdings Inc.
CEO: Zhilin Li